# OR2T7

## Overview
The OR2T7 gene encodes the olfactory receptor family 2 subfamily T member 7, a protein that belongs to the G-protein-coupled receptor (GPCR) superfamily. This receptor is primarily involved in the olfactory system, where it plays a critical role in the detection and transduction of odorant signals. The OR2T7 protein is characterized by its seven-transmembrane domain structure, which is typical of GPCRs and essential for its function in signal transduction. Upon binding specific odorant molecules, OR2T7 activates G-proteins, initiating a cascade of intracellular events that culminate in the perception of smell. Beyond its role in olfaction, OR2T7 has been implicated in certain pathological conditions, including cancer, where its mutations and expression levels may serve as potential biomarkers (Park2022Gene; Barnes2020Expert; Gorostiola2024Computational).

## Function
The OR2T7 gene encodes an olfactory receptor protein that is part of the G-protein-coupled receptor (GPCR) family, which plays a crucial role in the detection of odor molecules. These receptors are expressed in the olfactory epithelium, where they bind specific odorants. Upon binding an odorant, OR2T7 initiates a signal transduction pathway that involves the activation of G-proteins. This activation leads to a cascade of intracellular events, ultimately resulting in the generation of an electrical signal that is transmitted to the brain, contributing to the perception of smell (Barnes2020Expert).

The OR2T7 protein is characterized by a seven-transmembrane domain structure, typical of GPCRs, which facilitates its interaction with odorant molecules and subsequent signal transduction. This structure is essential for the receptor's ability to undergo conformational changes upon ligand binding, which is necessary for the activation of associated G-proteins (Barnes2020Expert).

In healthy human cells, the function of OR2T7 is integral to the olfactory system's ability to detect a wide range of odorants, contributing to the organism's ability to perceive and respond to environmental chemical cues (Barnes2020Expert).

## Clinical Significance
The OR2T7 gene, part of the olfactory receptor family, has been implicated in certain cancer types due to its mutations and altered expression levels. In glioblastoma, a type of brain cancer, a destabilizing mutation in OR2T7, specifically D125V, has been identified. This mutation affects receptor stability and activation, suggesting its potential role as a biomarker for cancer (Gorostiola2024Computational). Additionally, in the context of Xp11.2 translocation renal cell carcinoma (tRCC), OR2T7 is significantly downregulated in aggressive cases, with a log2 fold change of -7.47. This downregulation may contribute to the aggressive nature of the cancer, although the specific mechanisms remain unclear (Park2022Gene).

The use of computational tools, including machine learning, has been highlighted as a method to better understand GPCR signaling pathways, including those involving OR2T7, and their implications in cancer. These tools can predict interactions with G protein subunits and assess signaling biases, which are crucial for developing targeted therapies (Gorostiola2024Computational). Despite these findings, the clinical significance of OR2T7 mutations or expression changes outside of cancer contexts is not well-documented.


## References


[1. (Gorostiola2024Computational) Marina Gorostiola Gonz√°lez, Pepijn R. J. Rakers, Willem Jespers, Adriaan P. IJzerman, Laura H. Heitman, and Gerard J. P. van Westen. Computational characterization of membrane proteins as anticancer targets: current challenges and opportunities. International Journal of Molecular Sciences, 25(7):3698, March 2024. URL: http://dx.doi.org/10.3390/ijms25073698, doi:10.3390/ijms25073698. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms25073698)

[2. (Barnes2020Expert) If H. A. Barnes, Ximena Ibarra-Soria, Stephen Fitzgerald, Jose M. Gonzalez, Claire Davidson, Matthew P. Hardy, Deepa Manthravadi, Laura Van Gerven, Mark Jorissen, Zhen Zeng, Mona Khan, Peter Mombaerts, Jennifer Harrow, Darren W. Logan, and Adam Frankish. Expert curation of the human and mouse olfactory receptor gene repertoires identifies conserved coding regions split across two exons. BMC Genomics, March 2020. URL: http://dx.doi.org/10.1186/s12864-020-6583-3, doi:10.1186/s12864-020-6583-3. This article has 31 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12864-020-6583-3)

[3. (Park2022Gene) Jee Soo Park, Myung Eun Lee, Won Sik Jang, Jongchan Kim, Se Mi Park, and Won Sik Ham. Gene expression analysis of aggressive adult xp11.2 translocation renal cell carcinoma at clinical stage t1n0m0 to identify potential prognostic and therapeutic biomarkers. Biomedicines, 10(2):321, January 2022. URL: http://dx.doi.org/10.3390/biomedicines10020321, doi:10.3390/biomedicines10020321. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biomedicines10020321)